Kindly Select Licence Type

Single User
US$ 4125

US$3300

Multi Users (5)
US$ 7500

US$6000

CCorporate License
US$ 9000

US$7200

Kindly fill the below billing information


Order Summary

Global Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Investment Landscape 2025-2032

  • Report Id : 38399

  • Category : Pharma & Healthcare

  • Pages : 165

  • Format : PDF/Excel